A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

Filer Snapshot

LA JOLLA PHARMACEUTICAL CO

CIK 0000920465. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

1,496

Latest filing

14 Feb 2023

Industry

Biological Products, (No Disgnostic Substances)

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Go to filings Save page

Latest 13F portfolio

—

No parsed 13F portfolio row yet.

Browse latest 13F

Largest parsed holding

—

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

—

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Insider / owner context

—

No parsed Forms 3/4/5 owner position for this CIK.

Browse insider filings

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Source: SEC Schedule 13D/G

SC 13G/A filed on 14 Feb 2023 for CIK 0000920465.

View source filing

SEC industry group: Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
Business address: 201 Jones Road, Suite 400, Waltham, MA, 02451
Incorporated in: DE
Fiscal year end: 31 December

Filer intelligence

What SEC filings say about LA JOLLA PHARMACEUTICAL CO

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

SEC source mix

Counts show available parsed rows, not one combined ownership total.

No XML rows yet

13F portfolio No rows yet

Quarterly institutional portfolio holdings.

13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

No parsed ownership summary yet

We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.

SEC filing record

CIK 0000920465 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings

1,496

First seen

06 Feb 1996

Latest filing

14 Feb 2023

Entity

Company

Observed form types

SC 13G/A 15-12G SC 13D/A SC 13D 4 S-8 POS 25-NSE 8-K SC 14D9/A SC TO-T/A +46 more

CIK-linked evidence first

LA JOLLA PHARMACEUTICAL CO SEC filings LA JOLLA PHARMACEUTICAL CO insider transactions Open SEC filing index

Industry context: Biological Products, (No Disgnostic Substances).

Latest Filings

Showing the latest 12 of 866 SEC filings for LA JOLLA PHARMACEUTICAL CO.

Open full filing history

SC 13G/A File 005-44849